{
    "deck": {
        "metadata": {
            "title": "ADC Clinical Insights Deck",
            "version": "1.0",
            "theme_key": "clinical_modern"
        },
        "slides": [
            {
                "order": 2,
                "slide_type": "content",
                "title": "Attendee Demographics",
                "body": [
                    {
                        "component": "table",
                        "content": ""
                    },
                    {
                        "component": "text",
                        "content": " - The TROPION-Breast01 safety data for Dato-DXd compared to traditional chemotherapy were notably favored /n- Attendees agreed that Dato-DXd had a lower potential for severe side effects observed with other ADCs, such as ILD and severe diarrhea"
                    }
                ]
            },
            {
                "order": 1,
                "slide_type": "content",
                "title": "Attendee Demographics",
                "body": [
                    {
                        "component": "chart",
                        "chartType": "horizontal_bar_chart",
                        "name": "Years Post-Residency Treating Patients With BC",
                        "bucket_label": "Years",
                        "count_label": "Physicians",
                        "aggregations": {
                            "0 to 3": 10,
                            "4 to 6": 0,
                            "7 to 10": 10,
                            "11 to 15": 30,
                            "16 to 20": 30,
                            "21 to 25": 0,
                            ">25": 20
                        }
                    },
                    {
                        "component": "chart",
                        "chartType": "horizontal_bar_chart",
                        "name": "Patient Location:",
                        "bucket_label": "Physicians",
                        "count_label": "Patients",
                        "aggregations": {
                            "1 to 5": 0,
                            "6 to 10": 40,
                            "11 to 20": 50,
                            "21 to 30": 30,
                            "31 to 50": 10,
                            ">50": 20
                        }
                    },
                    {
                        "component": "chart",
                        "chartType": "donut_chart",
                        "name": "How comfortable are you managing ocular toxicities?",
                        "aggregations": {
                            "Treat the patient": 40,
                            "Refer to an optometrist": 20,
                            "Refer to ophthalmologist": 40
                        }
                    }
                ]
            }
        ]
    }
}